[1] Sakai T, Iino S, Okuno T, y otros. High Response Rates with Peginterferon Alfa-2a (40KD) (PEGASYS (R)) plus Ribavirin (COPEGUS (R)) in Treatment-Naive Japanese Chronic Hepatitis C Patients: A Randomized, Double-Blind, Multicenter, Phase III Trial. Presentado en la Semana de las Enfermedades Digestivas, 20-25 de mayo de 2006.
[2] Izumi N, Iino S, Okuno T, y otros. High Response Rates With Peginterferon Alfa-2a (40KD) (PEGASYS (R)) plus Ribavirin (COPEGUS (R)) in Japanese Non-Responders or Relapsers to Conventional interferón. Presentado en la Semana de las Enfermedades Digestivas, 20-25 de mayo de 2006.
[3] Tsubota A, Arase Y, Suzuki F, y otros. High-dose interferón alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load. Journal of Gastroenterology. 2004; 39(2):155-61.
[TAB]
Contacto:
Janet Kettels, Roche
+41-79-597-82-85 (móvil)
James Smith
Axon Communications
+44-208-822-6692
[FTAB]
Janet Kettels, Roche, +41-79-597-82-85 (móvil). James Smith, Axon Communications, +44-20-8822-6692
